As stated above, considering that we found increased TNBC percentage (around 3%) in patients with a family history of breast/ovarian cancer, and BRCA1 mutation is linked with increased TNBC percentage, common genetic mutations could potentially influence our results. This evidence concerns the gene BRCA1 and ovarian carcinoma.